Patent details

Basic Information

Publication number:

EP2265251

PCT Application Number:

PCT/US/2009/037077

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP097222780

PCT Publication Number:

WO/2009/117316

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES AYANT LA BIODISPONIBILITÉ SOUHAITABLE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT ERWÜNSCHTER BIOVERFÜGBARKEIT

SPC Number:

Dates

Filing date:

13/03/2009

Grant date:

27/05/2015

EP Publication Date:

27/05/2015

PCT Publication Date:

24/09/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

29/12/2010

EP B1 Publication Date:

27/05/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/03/2023

Expiration date:

13/03/2029

Renunciation date:

Revocation date:

13/11/2024

Annulment date:

Owner

From:

12/12/2019

 

 

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

History of Owners

From:

12/12/2019

To:

12/12/2019

Name:

ALCON RESEARCH, LLC

Address:

6201 South Freeway, 76134, Fort Worth, TX, United States (US)

From:

13/03/2009

To:

12/12/2019

Name:

Alcon Research Ltd.

Address:

6201 South Freeway, MS-TB4-8, Fort Worth, TX 76134-2099, United States (US)

Inventor

1

Name:

MRIDVIKA

Address:

Spain (ES)

2

Name:

GALÁN Francisco, Javier

Address:

Spain (ES)

3

Name:

JIMÉNEZ Nuria

Address:

Spain (ES)

4

Name:

MARTÍNEZ Carmen

Address:

Spain (ES)

5

Name:

CARRERAS Nuria

Address:

Spain (ES)

6

Name:

KABRA Bhagwati, P.

Address:

United States (US)

7

Name:

CUCHI Mónica

Address:

Spain (ES)

8

Name:

PUIG Elena, González

Address:

Spain (ES)

Priority

1

Priority Number:

37117 P

Priority Date:

17/03/2008

Priority Country:

United States (US)

2

Priority Number:

111920 P

Priority Date:

06/11/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 47/44;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2020/01

Publication date:

13/01/2020

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:

202503

Publication date:

15/01/2025

Description:

Revocation of the European patent

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000456A

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Fusion-Absorption

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

ALCON RESEARCH, LLC

Address:

6201 South Freeway, 76134, Fort Worth, TX, United States (US)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000456B

Date Registered:

12/12/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Novartis AG

Address:

., 4002, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

02/03/2022

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
12/12/2019	Request For Change	9
24/12/2019	Outgoing Correspondence	1